Electronic versions

DOI

  • Eva Kaltenthaler
  • Christopher Carroll
  • Daniel Hill-McManus
  • Alison Scope
  • Michael Holmes
  • Stephen Rice
  • Micah Rose
  • Paul Tappenden
  • Nerys Woolacott
Evidence Review Groups (ERGs) critically appraise company submissions as part of the National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA) process. As part of their critique of the evidence submitted by companies, the ERGs undertake exploratory analyses to explore uncertainties in the company's model. The aim of this study was to explore pre-defined factors that might influence or predict the extent of ERG exploratory analyses.
Original languageEnglish
Pages (from-to)99-108
Number of pages10
JournalPharmacoEconomics - Open
Volume1
Issue number2
DOIs
Publication statusPublished - Jun 2017
View graph of relations